Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC

Clinical trial NCT06768255 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06768255
Sponsor: Ding-Wei Ye
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Abiraterone Acetate MCRPC (metastatic Castration-resistant Prostate Cancer)

Start date: 2025-01-30
Primary completion: 2028-12-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.